Literature DB >> 28455824

Diallyl trisulfide ameliorates myocardial ischemia-reperfusion injury by reducing oxidative stress and endoplasmic reticulum stress-mediated apoptosis in type 1 diabetic rats: role of SIRT1 activation.

Liming Yu1, Shu Li2, Xinlong Tang3, Zhi Li1, Jian Zhang1, Xiaodong Xue1, Jinsong Han1, Yu Liu1, Yuji Zhang1, Yong Zhang1, Yinli Xu1, Yang Yang4,5,6, Huishan Wang7.   

Abstract

Diallyl trisulfide (DATS) protects against apoptosis during myocardial ischemia-reperfusion (MI/R) injury in diabetic state, although the underlying mechanisms remain poorly defined. Previously, we and others demonstrated that silent information regulator 1 (SIRT1) activation inhibited oxidative stress and endoplasmic reticulum (ER) stress during MI/R injury. We hypothesize that DATS reduces diabetic MI/R injury by activating SIRT1 signaling. Streptozotocin (STZ)-induced type 1 diabetic rats were subjected to MI/R surgery with or without perioperative administration of DATS (40 mg/kg). We found that DATS treatment markedly improved left ventricular systolic pressure and the first derivative of left ventricular pressure, reduced myocardial infarct size as well as serum creatine kinase and lactate dehydrogenase activities. Furthermore, the myocardial apoptosis was also suppressed by DATS as evidenced by reduced apoptotic index and cleaved caspase-3 expression. However, these effects were abolished by EX527 (the inhibitor of SIRT1 signaling, 5 mg/kg). We further found that DATS effectively upregulated SIRT1 expression and its nuclear distribution. Additionally, PERK/eIF2α/ATF4/CHOP-mediated ER stress-induced apoptosis was suppressed by DATS treatment. Moreover, DATS significantly activated Nrf-2/HO-1 antioxidant signaling pathway, thus reducing Nox-2/4 expressions. However, the ameliorative effects of DATS on oxidative stress and ER stress-mediated myocardial apoptosis were inhibited by EX527 administration. Taken together, these data suggest that perioperative DATS treatment effectively ameliorates MI/R injury in type 1 diabetic setting by enhancing cardiac SIRT1 signaling. SIRT1 activation not only upregulated Nrf-2/HO-1-mediated antioxidant signaling pathway but also suppressed PERK/eIF2α/ATF4/CHOP-mediated ER stress level, thus reducing myocardial apoptosis and eventually preserving cardiac function.

Entities:  

Keywords:  Diallyl trisulfide; Endoplasmic reticulum stress; Myocardial ischemia-reperfusion; Oxidative stress; SIRT1; Type 1 diabetes

Mesh:

Substances:

Year:  2017        PMID: 28455824     DOI: 10.1007/s10495-017-1378-y

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  37 in total

1.  The cardioprotective effects of diallyl trisulfide on diabetic rats with ex vivo induced ischemia/reperfusion injury.

Authors:  Jovana N Jeremic; Vladimir Lj Jakovljevic; Vladimir I Zivkovic; Ivan M Srejovic; Jovana V Bradic; Sergey Bolevich; Tamara R Nikolic Turnic; Slobodanka Lj Mitrovic; Nemanja U Jovicic; Suresh C Tyagi; Nevena S Jeremic
Journal:  Mol Cell Biochem       Date:  2019-07-06       Impact factor: 3.396

Review 2.  Ischemic brain injury in diabetes and endoplasmic reticulum stress.

Authors:  Ashish K Rehni; Sunjoo Cho; Kunjan R Dave
Journal:  Neurochem Int       Date:  2021-11-01       Impact factor: 3.921

Review 3.  Role of Oxidative Stress in Reperfusion following Myocardial Ischemia and Its Treatments.

Authors:  Mi Xiang; Yingdong Lu; Laiyun Xin; Jialiang Gao; Chang Shang; Zhilin Jiang; Hongchen Lin; Xuqin Fang; Yi Qu; Yuling Wang; Zihuan Shen; Mingjing Zhao; Xiangning Cui
Journal:  Oxid Med Cell Longev       Date:  2021-05-18       Impact factor: 6.543

4.  Honokiol Ameliorates Myocardial Ischemia/Reperfusion Injury in Type 1 Diabetic Rats by Reducing Oxidative Stress and Apoptosis through Activating the SIRT1-Nrf2 Signaling Pathway.

Authors:  Bin Zhang; Mengen Zhai; Buying Li; Zhenhua Liu; Kaifeng Li; Liqing Jiang; Meng Zhang; Wei Yi; Jian Yang; Dinghua Yi; Hongliang Liang; Zhenxiao Jin; Weixun Duan; Shiqiang Yu
Journal:  Oxid Med Cell Longev       Date:  2018-02-20       Impact factor: 6.543

5.  Exendin-4 Protects Against Myocardial Ischemia-Reperfusion Injury by Upregulation of SIRT1 and SIRT3 and Activation of AMPK.

Authors:  Refaat A Eid; Mashael Mohammed Bin-Meferij; Attalla Farag El-Kott; Samy M Eleawa; Mohamed Samir Ahmed Zaki; Mubarak Al-Shraim; Fahmy El-Sayed; Muhammad Alaa Eldeen; Mahmoud A Alkhateeb; Samah A Alharbi; Hussain Aldera; Mohammad A Khalil
Journal:  J Cardiovasc Transl Res       Date:  2020-04-01       Impact factor: 4.132

6.  Febuxostat attenuates ER stress mediated kidney injury in a rat model of hyperuricemic nephropathy.

Authors:  Li He; Ying Fan; Wenzhen Xiao; Teng Chen; Jiejun Wen; Yang Dong; Yiyun Wang; Shiqi Li; Rui Xue; Liyang Zheng; John Cijiang He; Niansong Wang
Journal:  Oncotarget       Date:  2017-11-30

7.  Polydatin Protects Diabetic Heart against Ischemia-Reperfusion Injury via Notch1/Hes1-Mediated Activation of Pten/Akt Signaling.

Authors:  Liming Yu; Zhi Li; Xue Dong; Xiaodong Xue; Yu Liu; Shu Xu; Jian Zhang; Jinsong Han; Yang Yang; Huishan Wang
Journal:  Oxid Med Cell Longev       Date:  2018-02-13       Impact factor: 6.543

8.  Araloside C Prevents Hypoxia/Reoxygenation-Induced Endoplasmic Reticulum Stress via Increasing Heat Shock Protein 90 in H9c2 Cardiomyocytes.

Authors:  Yuyang Du; Min Wang; Xuesong Liu; Jingyi Zhang; Xudong Xu; Huibo Xu; Guibo Sun; Xiaobo Sun
Journal:  Front Pharmacol       Date:  2018-04-17       Impact factor: 5.810

9.  CCAAT/enhancer binding protein homologous protein knockdown alleviates hypoxia-induced myocardial injury in rat cardiomyocytes exposed to high glucose.

Authors:  Wenqi Yang; Fang Wu; Ting Luo; Yuelan Zhang
Journal:  Exp Ther Med       Date:  2018-03-09       Impact factor: 2.447

10.  Sirt1 Activation by Post-ischemic Treatment With Lumbrokinase Protects Against Myocardial Ischemia-Reperfusion Injury.

Authors:  Yi-Hsin Wang; Shun-An Li; Chao-Hsin Huang; Hsing-Hui Su; Yi-Hung Chen; Jinghua T Chang; Shiang-Suo Huang
Journal:  Front Pharmacol       Date:  2018-06-15       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.